SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
48 hedge funds and large institutions have $33.5M invested in SQZ Biotechnologies Company in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 53 → 48 (-5)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
29% less capital invested
Capital invested by funds: $47.1M → $33.5M (-$13.7M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$262K |
| 2 |
RC
RBF Capital
San Francisco,
California
|
+$150K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$75.5K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$75K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$385K |
| 2 |
Millennium Management
New York
|
-$293K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$139K |
| 4 |
Morgan Stanley
New York
|
-$71.8K |
| 5 |
Goldman Sachs
New York
|
-$66.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Osaic Holdings
Scottsdale,
Arizona
| – | -$1K | -256 | Closed |
|
52
Fidelity Investments
Boston,
Massachusetts
| – | -$1K | -209 | Closed |
|
53
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -194 | Closed |
|
54
Simplex Trading
Chicago,
Illinois
| – | -$486 | -162 | -29% |
|
55
Wells Fargo
San Francisco,
California
| – | +$12 | +4 | +3% |
|
SQZ Hedge Fund Activity: Q3 2022 in Review
48 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2022, worth a combined $33.5M — down 29% from $47.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SQZ and 4 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 11 added.
The largest buyer was 683 Capital Management, adding an estimated $262K. The largest seller was JP Morgan Chase, cutting an estimated $385K.
- 48 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2022, down from 53 in Q2 2022.
- Funds reported $33.5M of SQZ Biotechnologies Company stock for Q3 2022, down 29% quarter-over-quarter.
- 4 funds opened new SQZ Biotechnologies Company positions in Q3 2022 and 9 closed out, a net change of -5 holders.
- The largest SQZ Biotechnologies Company buyer in Q3 2022 was 683 Capital Management, an estimated $262K added.
- The largest SQZ Biotechnologies Company seller in Q3 2022 was JP Morgan Chase, an estimated $385K sold.
Based on aggregated 13F filings for Q3 2022.